MDM2 and skin squamous cell carcinoma: The MDM2‐p53 signaling pathway in keratinocytes has been reported to promote cell proliferation by inhibiting p53 activity, thereby contributing to the development of squamous cell carcinoma of the skin.[36] However, the role of MDM2/p53 in the progression of psoriasis and the underlying mechanism remains unclear.